Broad capabilities, established expertise


As one of the world’s most renowned companies for contract development and manufacturing, we are recognized for our reliable, high-quality service, our global capacity, our innovative technology platforms, and our extensive experience. In 2019 we provided manufacturing services for more than 300 commercial molecules and supported the development of more than 700 pre-clinical and clinical molecules in small and large molecules as well as supporting the launch of pioneering autologous cell therapies.

 

Success for us is when you, as our partner, are fully satisfied. We continuously improve and innovate to meet your expectations and improve your chances of business success. Our broad capabilities span across biologics, small molecules, bioconjugates, and cell and gene therapies. We manage projects from pre-clinical stage through to commercialization, and our expertise covers both drug substance and drug product.

Trending now

The Evolving Role of the CDMO: Integrated First-in-Human Services
Watch 6 on-demand presentations from industry and subject matter experts from our recent symposium.
Lonza and Ankyra Therapeutics Sign Agreement to Develop and Manufacture a Cytokine Fusion Protein
Ankyra will leverage Lonza’s expertise with next-generation modalities to take their first complex molecule targeting intratumoral administration in solid tumors into clinical development
New job openings in Cell & Gene
Lonza is a world leader in cell & gene therapy manufacturing, working across a variety of modalities. In this fast-paced and high-growth environment, we are always looking to hire new talent across our network. Open positions include roles in QA/QC, Process Development, Assay Development, Manufacturing Science and Technologies (MSAT), Regulatory Affairs and Operations.
We believe that the best outcome – for you and for your patients – can only come as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.

In the news


We have a broad view on the industry, and a depth of experience in developing and manufacturing therapies. Our scientific teams focus on devising credible, game-changing solutions that create value for our customers today by delivering the medicines of tomorrow.

View press releases

Our global footprint


With 37 sites across three continents and 11,148 employees, we capitalize on our global footprint and have the flexibility to address regional and even local marketplace needs.

View our locations